Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC
Clinical trial NCT07076979 · RECRUITING
Trial details
- NCT number
- NCT07076979
- Sponsor
- Shanghai Minimally Invasive Surgery Center
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-06-15
- Primary completion
- 2028-07-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.